| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adenylyl cyclase signalling complexes – Pharmacological challenges and opportunities
|
Halls, Michelle L.
|
|
2017
|
172 |
C |
p. 171-180
|
article
|
| 2 |
Allopurinol as a therapeutic option in cardiovascular disease
|
Okafor, Osita N
|
|
2017
|
172 |
C |
p. 139-150
|
article
|
| 3 |
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
|
Faria, Alyssa
|
|
2017
|
172 |
C |
p. 50-62
|
article
|
| 4 |
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets
|
Deshpande, Deepak A.
|
|
2017
|
172 |
C |
p. 116-126
|
article
|
| 5 |
Complement: A primer for the coming therapeutic revolution
|
Barnum, Scott R.
|
|
2017
|
172 |
C |
p. 63-72
|
article
|
| 6 |
Current and novel insights into the neurophysiology of migraine and its implications for therapeutics
|
Akerman, Simon
|
|
2017
|
172 |
C |
p. 151-170
|
article
|
| 7 |
Human presynaptic receptors
|
Schlicker, Eberhard
|
|
2017
|
172 |
C |
p. 1-21
|
article
|
| 8 |
Maximising the potential of AKT inhibitors as anti-cancer treatments
|
Brown, Jessica S.
|
|
2017
|
172 |
C |
p. 101-115
|
article
|
| 9 |
MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
|
Nassar, Farah J
|
|
2017
|
172 |
C |
p. 34-49
|
article
|
| 10 |
NaV1.7 as a pain target – From gene to pharmacology
|
Vetter, Irina
|
|
2017
|
172 |
C |
p. 73-100
|
article
|
| 11 |
Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders
|
Hasegawa, Masato
|
|
2017
|
172 |
C |
p. 22-33
|
article
|
| 12 |
The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance
|
Qiu, Guan-Zhong
|
|
2017
|
172 |
C |
p. 127-138
|
article
|
| 13 |
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
|
Carr, Daniel F.
|
|
2017
|
172 |
C |
p. 181-194
|
article
|
Journal description